HSANZ Free Communications 1: Acute leukaemia and MDS
Tracks
HSANZ
| Monday, October 19, 2026 |
| 8:30 AM - 10:00 AM |
Speaker
Dr Ashish Bajel
Outcomes of patients with relapsed/refractory FLT3mut+ acute myeloid leukemia who resumed gilteritinib therapy after HSCT: Post hoc analysis from the ADMIRAL and COMMODORE trials
8:30 AM - 8:45 AM
Prof Hongyan Liao
Associate Professor
West China Hospital Of Sichuan University
Integrating leukemia stem cells into minimal residual disease evaluation predicts survival of acute myeloid leukemia
8:45 AM - 9:00 AM
Ms Kelly Lim
Phd Candidate
Adelaide University
AML with RAS pathway mutations is resistant to venetoclax but sensitive to GM-CSF neutralisation
9:00 AM - 9:15 AM
Dr Francis Baumgartner
Hematopathology Fellow
Peter MacCallum Cancer Centre
Development of same-day comprehensive molecular diagnostics in acute leukaemia using long-read sequencing
9:15 AM - 9:30 AM
Dr Sepideh Azizi
Postdoctoral Research
Adelaide University
TGF-β Signalling Governs Quiescence and Chemoresistance in CD123High Leukemic Stem Cells
9:30 AM - 9:45 AM
Dr Zhi Han Yeoh
Haematologist
Peter MacCallum Cancer Centre & Royal Melbourne Hospital
Investigating clonal haematopoiesis and risk factors for myeloid evolution (I-CHROME) study
9:45 AM - 10:00 AM
